Recruiting NA Glaucoma, Primary Open Angle

New treatment option for Glaucoma, Primary Open Angle

Official title Caffeine Consumption in Glaucoma Patients and Healthy Subjects

ClinicalTrials.gov ID: NCT03675412

What this study is testing

What it's testing
Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 90. Healthy volunteers may be eligible.

You may be able to join if

  • age 18 to 90 years
  • diagnosis of primary open angle glaucoma (Mild, Moderate and Advanced)
  • healthy people with no eye disease

You likely can't join if

  • Diseases, ophthalmic or systemic, that are likely to affect OCTA results
  • greater than moderate cataract
  • nystagmus
  • inability to look at target
  • macular degeneration other than mild drusen or pigmentary changes
  • diabetic retinopathy
See the full eligibility criteria
Who can join
  • age 18 to 90 years
  • diagnosis of primary open angle glaucoma (Mild, Moderate and Advanced)
  • healthy people with no eye disease
What rules you out
  • Diseases, ophthalmic or systemic, that are likely to affect OCTA results
  • greater than moderate cataract
  • nystagmus
  • inability to look at target
  • macular degeneration other than mild drusen or pigmentary changes
  • diabetic retinopathy
  • neovascular glaucoma or non-glaucoma optic neuropathies
  • current macular edema, prior laser to retina, inflammatory retinopathy or choroidopathy
  • keratoconus, corneal ectasia, central corneal scarring
  • rheumatologic diseases or Raynaud's phenomena
  • pregnant and lactating women
  • mental illness or alcohol addiction
  • pre-existing bladder symptoms, cardiac disease or sleep disorder
  • refractive spherical diopter greater than 5 or cylinder greater than 3
  • possible tolerance to caffeine (drinking more than 1 cup coffee per day).

The study team makes the final eligibility decision.

Where it's taking place

  • Philadelphia, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.